These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 6256116)

  • 1. Cyclic AMP generation in hypothalamus of hypertension-prone and -resistant rats.
    Kobrin I; Ebstein R; Ben-Ishay D
    Clin Sci (Lond); 1980 Dec; 59 Suppl 6():247s-249s. PubMed ID: 6256116
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cyclic AMP generation in medulla oblongata and hypothalamus of hypertension-prone and -resistant rats.
    Kobrin I; Ebstein R; Belmaker R; Ben-Ishay D
    J Neurochem; 1981 Mar; 36(3):1285-8. PubMed ID: 6259286
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhibition of 3',5'-nucleotide phosphodiesterase and the stimulation of cerebral cyclic AMP formation by biogenic amines in vitro and in vivo.
    Nahorski SR; Rogers KJ
    Neuropharmacology; 1976 Oct; 15(10):609-12. PubMed ID: 186725
    [No Abstract]   [Full Text] [Related]  

  • 4. The effects of theophylline and 4-(3-butoxy-4-methoxybenzyl)-2-imidazolidinone (RO 20-1724) on protein secretion from rat parotid gland.
    Afari G; Tenenhouse A; Vachon C
    Br J Pharmacol; 1982 Nov; 77(3):405-11. PubMed ID: 6291691
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Distinguishing traits in the Sabra hypertension-prone (SBH) and hypertension-resistant (SBN) rats.
    Ben-Ishay D; Zamir N; Feurstein G; Kobrin I; Le Quan-Bui KH; Devynck MA
    Clin Exp Hypertens (1978); 1981; 3(4):737-47. PubMed ID: 6117432
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cardiotonic actions of selective phosphodiesterase inhibitors in rat isolated ventricular cardiomyocytes.
    Kelso EJ; McDermott BJ; Silke B
    Br J Pharmacol; 1993 Dec; 110(4):1387-94. PubMed ID: 8306078
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of opioid peptides on L-noradrenaline-stimulated cyclic AMP formation in homogenates of rat cerebral cortex and hypothalamus.
    Tsang D; Tan AT; Henry JL; Lal S
    Brain Res; 1978 Sep; 152(3):521-7. PubMed ID: 210878
    [TBL] [Abstract][Full Text] [Related]  

  • 8. 4-(3-Cyclopentyloxy-4-methoxyphenyl)-2-pyrrolidone (ZK 62711): a potent inhibitor of adenosine cyclic 3',5'-monophosphate phosphodiesterases in homogenates and tissue slices from rat brain.
    Schwabe U; Miyake M; Ohga Y; Daly JW
    Mol Pharmacol; 1976 Nov; 12(6):900-10. PubMed ID: 187926
    [No Abstract]   [Full Text] [Related]  

  • 9. Are histamine H2-receptor depressions of neuronal activity in tissue cultures from rat hypothalamus mediated through cyclic adenosine monophosphate?
    Geller HM
    Neurosci Lett; 1979 Sep; 14(1):49-53. PubMed ID: 93718
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Treatment with the type IV phosphodiesterase inhibitor Ro 20-1724 protects renal and mesenteric blood flow in endotoxemic rats treated with norepinephrine.
    Carcillo JA; Herzer WA; Mi Z; Thomas NJ; Jackson EK
    J Pharmacol Exp Ther; 1996 Dec; 279(3):1197-204. PubMed ID: 8968341
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Involvement of adenosine-sensitive cyclic AMP-generating systems in cobalt-induced epileptic activity in the rat.
    Hattori Y; Moriwaki A; Hayashi Y; Hori Y
    J Neurochem; 1993 Dec; 61(6):2169-74. PubMed ID: 8245969
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Role of adenosine 3',5'-cyclic monophosphate in adrenoceptor-mediated control of 3H-noradrenaline secretion in guinea-pig ileum myenteric nerve terminals.
    Alberts P; Ogren VR; Sellström AI
    Naunyn Schmiedebergs Arch Pharmacol; 1985 Aug; 330(2):114-20. PubMed ID: 2413372
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Decreased cAMP content of the hypothalamus of genetically hypertensive rats.
    Schmid G; Hempel K; Heidland A
    Naunyn Schmiedebergs Arch Pharmacol; 1978 May; 302(3):341-3. PubMed ID: 208011
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Exposure of human seminal vesicle tissue to phosphodiesterase (PDE) inhibitors antagonizes the contraction induced by norepinephrine and increases production of cyclic nucleotides.
    Birowo P; Uckert S; Kedia GT; Sonnenberg JE; Sandner P; Thon WF; Scheller F; Rahardjo D; Kuczyk MA
    Urology; 2010 Dec; 76(6):1518.e1-6. PubMed ID: 20970829
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Phosphodiesterase inhibitors: their comparative effectiveness in vitro in various organs.
    Adachi K; Numano F
    Jpn J Pharmacol; 1977 Feb; 27(1):97-103. PubMed ID: 194077
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Chronic type IV phosphodiesterase inhibition protects glomerular filtration rate and renal and mesenteric blood flow in a zymosan-induced model of multiple organ dysfunction syndrome treated with norepinephrine.
    Thomas NJ; Carcillo JA; Herzer WA; Mi Z; Jackson EK
    J Pharmacol Exp Ther; 2001 Jan; 296(1):168-74. PubMed ID: 11123377
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cyclic adenosine 3',5'-monophosphate mediates beta-receptor actions of noradrenaline in rat hippocampal pyramidal cells.
    Madison DV; Nicoll RA
    J Physiol; 1986 Mar; 372():245-59. PubMed ID: 2425084
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The effect of lithium on noradrenaline-induced cyclic AMP accumulation in rat brain: inhibition after chronic treatment and absence of supersensitivity.
    Ebstein RP; Hermoni M; Belmaker RH
    J Pharmacol Exp Ther; 1980 Apr; 213(1):161-7. PubMed ID: 6244392
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhibition of bradykinin stimulation of renal medullary prostaglandin E2 synthesis by phosphodiesterase inhibitors.
    Rapp NS; Zenser TV; Mattammal MB; Davis BB
    J Pharmacol Exp Ther; 1981 Nov; 219(2):442-6. PubMed ID: 6169824
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of a cardiotonic quinolinone derivative Y-20487 on the isoproterenol-induced positive inotropic action and cyclic AMP accumulation in rat ventricular myocardium: comparison with rolipram, Ro 20-1724, milrinone, and isobutylmethylxanthine.
    Katano Y; Endoh M
    J Cardiovasc Pharmacol; 1992; 20(5):715-22. PubMed ID: 1280732
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.